JPY 1440.0
(-0.89%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 20.94 Billion JPY | -1.56% |
2022 | 21.27 Billion JPY | -1.6% |
2021 | 21.62 Billion JPY | -1.18% |
2020 | 21.88 Billion JPY | -7.25% |
2019 | 23.59 Billion JPY | -1.79% |
2018 | 24.02 Billion JPY | 346.59% |
2017 | 5.37 Billion JPY | -2.68% |
2016 | 5.52 Billion JPY | -14.22% |
2015 | 6.44 Billion JPY | 62.74% |
2014 | 3.95 Billion JPY | 74.64% |
2013 | 2.26 Billion JPY | 11.18% |
2012 | 2.03 Billion JPY | -42.71% |
2011 | 3.55 Billion JPY | -52.53% |
2010 | 7.49 Billion JPY | 114.47% |
2009 | 3.49 Billion JPY | -34.56% |
2008 | 5.34 Billion JPY | 100.9% |
2007 | 2.65 Billion JPY | 78.46% |
2006 | 1.49 Billion JPY | -21.62% |
2005 | 1.9 Billion JPY | 0.0% |
2004 | - JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 20.68 Billion JPY | -1.25% |
2023 Q2 | 20.83 Billion JPY | -0.24% |
2023 Q3 | 20.78 Billion JPY | -0.24% |
2023 FY | 20.94 Billion JPY | -1.56% |
2023 Q1 | 20.88 Billion JPY | -1.84% |
2023 Q4 | 20.94 Billion JPY | 0.77% |
2022 Q1 | 21.08 Billion JPY | -2.49% |
2022 Q3 | 20.98 Billion JPY | -0.24% |
2022 FY | 21.27 Billion JPY | -1.6% |
2022 Q2 | 21.03 Billion JPY | -0.24% |
2022 Q4 | 21.27 Billion JPY | 1.39% |
2021 Q4 | 21.62 Billion JPY | 2.07% |
2021 Q1 | 21.28 Billion JPY | -2.72% |
2021 Q2 | 21.23 Billion JPY | -0.23% |
2021 Q3 | 21.18 Billion JPY | -0.24% |
2021 FY | 21.62 Billion JPY | -1.18% |
2020 FY | 21.88 Billion JPY | -7.25% |
2020 Q3 | 21.41 Billion JPY | -0.94% |
2020 Q4 | 21.88 Billion JPY | 2.2% |
2020 Q1 | 22.83 Billion JPY | -3.2% |
2020 Q2 | 21.61 Billion JPY | -5.36% |
2019 FY | 23.59 Billion JPY | -1.79% |
2019 Q1 | 23.39 Billion JPY | -2.6% |
2019 Q4 | 23.59 Billion JPY | 2.05% |
2019 Q2 | 23.22 Billion JPY | -0.74% |
2019 Q3 | 23.11 Billion JPY | -0.46% |
2018 Q2 | 3.88 Billion JPY | -16.32% |
2018 Q4 | 24.02 Billion JPY | 1.35% |
2018 FY | 24.02 Billion JPY | 346.59% |
2018 Q1 | 4.63 Billion JPY | -13.78% |
2018 Q3 | 23.7 Billion JPY | 510.72% |
2017 Q3 | 5.25 Billion JPY | 13.51% |
2017 FY | 5.37 Billion JPY | -2.68% |
2017 Q4 | 5.37 Billion JPY | 2.44% |
2017 Q2 | 4.62 Billion JPY | 1.51% |
2017 Q1 | 4.55 Billion JPY | -17.55% |
2016 Q4 | 5.52 Billion JPY | -3.76% |
2016 Q3 | 5.74 Billion JPY | 9.35% |
2016 Q1 | 5.66 Billion JPY | -12.12% |
2016 FY | 5.52 Billion JPY | -14.22% |
2016 Q2 | 5.25 Billion JPY | -7.24% |
2015 Q3 | 3.67 Billion JPY | -0.54% |
2015 Q4 | 6.44 Billion JPY | 75.18% |
2015 FY | 6.44 Billion JPY | 62.74% |
2015 Q1 | 3.76 Billion JPY | -4.85% |
2015 Q2 | 3.69 Billion JPY | -1.83% |
2014 Q4 | 3.95 Billion JPY | 246.98% |
2014 Q3 | 1.14 Billion JPY | -1.38% |
2014 Q1 | 1.63 Billion JPY | -27.83% |
2014 Q2 | 1.15 Billion JPY | -29.28% |
2014 FY | 3.95 Billion JPY | 74.64% |
2013 Q2 | 1.99 Billion JPY | 4.19% |
2013 Q1 | 1.91 Billion JPY | -6.33% |
2013 FY | 2.26 Billion JPY | 11.18% |
2013 Q4 | 2.26 Billion JPY | 13.69% |
2013 Q3 | 1.99 Billion JPY | 0.2% |
2012 Q3 | 1.81 Billion JPY | -21.23% |
2012 Q2 | 2.3 Billion JPY | -27.4% |
2012 Q1 | 3.17 Billion JPY | -10.68% |
2012 FY | 2.03 Billion JPY | -42.71% |
2012 Q4 | 2.03 Billion JPY | 12.16% |
2011 FY | 3.55 Billion JPY | -52.53% |
2011 Q3 | 3.65 Billion JPY | 7.79% |
2011 Q2 | 3.39 Billion JPY | -27.27% |
2011 Q1 | 4.66 Billion JPY | -37.84% |
2011 Q4 | 3.55 Billion JPY | -2.6% |
2010 Q2 | 3.21 Billion JPY | -1.89% |
2010 FY | 7.49 Billion JPY | 114.47% |
2010 Q1 | 3.27 Billion JPY | -6.32% |
2010 Q3 | 7.68 Billion JPY | 139.06% |
2010 Q4 | 7.49 Billion JPY | -2.38% |
2009 Q4 | 3.49 Billion JPY | -7.1% |
2009 Q3 | 3.76 Billion JPY | 0.88% |
2009 FY | 3.49 Billion JPY | -34.56% |
2009 Q2 | 3.73 Billion JPY | 0.0% |
2008 Q4 | 5.34 Billion JPY | 18.5% |
2008 FY | 5.34 Billion JPY | 100.9% |
2008 Q3 | 4.5 Billion JPY | 0.0% |
2007 FY | 2.65 Billion JPY | 78.46% |
2006 FY | 1.49 Billion JPY | -21.62% |
2005 FY | 1.9 Billion JPY | 0.0% |
2004 FY | - JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -24.007% |
Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.568% |
Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 95.0% |
Shionogi & Co., Ltd. | 11.62 Billion JPY | -80.258% |
Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -20735.779% |
Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -629.318% |
Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -444.052% |
Eisai Co., Ltd. | 206.74 Billion JPY | 89.869% |
Morishita Jintan Co., Ltd. | 425 Million JPY | -4828.471% |
Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -897.429% |
Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -5576.423% |
Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -64.644% |
Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | -23.35% |
Tsumura & Co. | 79.69 Billion JPY | 73.716% |
Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -1112.855% |
Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -8484.426% |
Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 89.649% |
Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 27.643% |
Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 55.983% |
Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -449.908% |
Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -140.234% |
SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
MedRx Co., Ltd | - JPY | -Infinity% |
Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
Solasia Pharma K.K. | 60 Million JPY | -34810.0% |
Modalis Therapeutics Corporation | 412.5 Million JPY | -4977.818% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -120.833% |
Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 74.73% |
Cyfuse Biomedical K.K. | 913 Million JPY | -2194.195% |
Toho Holdings Co., Ltd. | 30.24 Billion JPY | 30.743% |
Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -641.376% |